Treatment With Anifrolumab for Discoid Lupus Erythematosus
JAMA Dermatology · 01.02.2023 · 159 (2) · 224
DOI: 10.1001/jamadermatol.2022.5242 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Dermatology, erschienen am 01.02.2023. Verfasst von Francesca Trentin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Lupus Erythematosus, Discoid. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 6 Literaturangaben.
Abstract (Originalsprache)
This case report describes 2 women with severe and refractory discoid lupus erythematosus that was treated with anifrolumab.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Rheumatology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
- Department of Medical Biotechnologies, University of Siena, Siena, Italy.
Zitieren
APA
Trentin, F., Tani, C., Elefante, E., Stagnaro, C., Zucchi, D., & Mosca, M. (2023). Treatment With Anifrolumab for Discoid Lupus Erythematosus. JAMA Dermatology, 159(2), 224. https://doi.org/10.1001/jamadermatol.2022.5242
Vancouver
Trentin F, Tani C, Elefante E, Stagnaro C, Zucchi D, Mosca M. Treatment With Anifrolumab for Discoid Lupus Erythematosus. JAMA Dermatology. 2023;159(2):224. doi:10.1001/jamadermatol.2022.5242
BibTeX
@article{Trentin2023,
author = {Trentin, Francesca and Tani, Chiara and Elefante, Elena and Stagnaro, Chiara and Zucchi, Dina and Mosca, Marta},
title = {Treatment With Anifrolumab for Discoid Lupus Erythematosus},
journal = {JAMA Dermatology},
year = {2023},
volume = {159},
number = {2},
pages = {224},
doi = {10.1001/jamadermatol.2022.5242}
}
EUVIMED